ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Ex Vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates

B. Wiegmann,1 R. BellmasSanz,2 C. Neudörfl,2 C. Kühn,1 I. Tudorache,1 M. Avsar,1 A. Haverich,1 G. Warnecke,1 C. Falk.2

1Department of Cardiothoracic, Transplantation, Vascular Surgery, Hannover Medical School, Hannover, Germany
2Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.

Meeting: 2018 American Transplant Congress

Abstract number: A59

Keywords: Endothelial activation, Lung preservation, Lung transplantation

Session Information

Session Name: Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Purpose

The INSPIRE trial revealed significant reduction of PGD grade 3, i.e. less ischemia reperfusion injury (IRI) using the Organ Care System (OCS) compared to controls for lung preservation. In order to investigate endothelial mechanisms initiated by cold vs. normothermic preservation, blood, perfusates of INSPIRE patients were assessed for proteins involved in endothelial integrity. We hypothesized that OCS preservation also supports endothelial integrity and an anti-inflammatory milieu.

Methods

Blood plasma pre, T0, T24 post Tx and perfusion solutions from 33 OCS and 26 SOC patients with control-preserved lungs were analysed for 100 cytokines, angiogenic factors, by multiplex assays. Donor and recipient demographics, cold ischemic times and PGD scores were assessed and correlated with protein levels.

Results

Clinical evaluation (OCS/control) revealed mean recipient age: 50 vs. 49 years, diagnosis: idiopathic fibrosis (n=17/10), cystic fibrosis (n=7/8), idiopathic pulmonary hypertension (n=3/3) and emphysema (n=6/5), mean total cold ischemic times (CIT) 258±6 vs. 549±22 min (p<0.0001). In the OCS group, no cumulative PGD score > 2 was observed compared to 19% PGD3 in SOC (p=0.035). Less IRI in OCS patients was shown by significantly reduced IL-6, CXCL8, CXCL10, CCL2 plasma levels at T0. OCS plasma levels at T0 were significantly lower for sCD31 (p=0.002), ICAM-1 (p=0.025), PAI-1 (p=0.03), leading to a higher PAI-1/uPA ratio of 82 in OCS compared to 67 in SOC. Lower VCAM-1, IGFBP-1, Ang-2, uPA, sHer2/neu, sVEGFR2 levels were detected in OCS compared to SOC recipients but did not reach statistical significance. Plasma levels of endoglin (CD105, p=0.01), PlGF (p=0.02) correlated with CIT. In contrast to IL-6 in SOC, none of these proteins showed a PGD correlation at T0 or T24. Significantly higher concentrations of these proteins were measured in OCS vs. SOC perfusates (p<0.01).

Conclusion

During normothermic lung preservation using the OCS system, reduced IRI is accompanied with protection of the endothelium, which can be detected by lower T0 plasma levels of endothelial activation markers. Thus, lung preservation using the OCS initiates an anti-inflammatory cascade and a tissue-protective milieu resulting in improved graft function.

CITATION INFORMATION: Wiegmann B., BellmasSanz R., Neudörfl C., Kühn C., Tudorache I., Avsar M., Haverich A., Warnecke G., Falk C. Ex Vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Wiegmann B, BellmasSanz R, Neudörfl C, Kühn C, Tudorache I, Avsar M, Haverich A, Warnecke G, Falk C. Ex Vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates [abstract]. https://atcmeetingabstracts.com/abstract/ex-vivo-lung-perfusion-using-the-portable-ocs-maintains-endothelial-integrity-in-the-context-of-reduced-severe-pgd-rates/. Accessed May 9, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences